| EMA number | EMEA/H/C/004154 |
| ATC code | L01CD01 |
| Authorisation | 20 November 2018 |
| Withdrawn | 9 February 2024 |
| Revision | 7 |
Apealea in combination with carboplatin is indicated for the treatment of adult patients with first relapse of platinum?sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.